>>> US Gapping up

Gapping up 
In reaction to strong earnings/guidance:
  • VNDA +25.6%, DXCM +19.5%, ASRT +17.8%, IVC +14.1%, LVGO +13.4%, CECO +13.2%, CNDT +11.8%, MEET +11.8%, ELF +11.5%, BL +11.5%, JE +11.3%, EYE +11.2%, TXMD +9.9%, GDDY +9.6% (also announces new $500 mln buyback program), MBUU +9.6%, LXRX +9.4%, ANGI +9.3%, SAIL +9.1%, RL +9%, MT +7.3%, DNR +7%, BIDU +6.9%, IIPR +6.6%, IQ +6.2%, QCOM +5.5% (also appoints Akash Palkhiwala as CFO), NKTR +5.5%, FOCS +5.2%, TRGP +5%, ALB +4.9% (also filed mixed securities shelf offering), AEL +4.9%, NEX +4.9%, RDFN +4.8%, EBS +4.7%, XRAY +4.5%, CAH +4.1%, KDP +3.8%, NVRO +3.7% (also announced CFO retirement), PROS +3.5%, ECPG +3.4%, TTGT +3.3%, GOGO +3.2%, FISV +3.1%, ORA +2.9%, RDCM +2.9%, NLSN +2.8% (also completes strategic review -- confirms plans to split, will reduce quarterly cash dividend payment to $0.06 from $0.35) WYNN +2.7% (also filed mixed securities shelf offering), ATSG +2.5%, ZTS +2.5%, ET +2.4%, FOXA +2.4% (also authorized $2 bln stock repurchase program), PAAS +2.4%, AZUL +2.4%, TLND +2.3%, NRG +2.3%, MRO +2.2%, ERI +2.1%, ADNT +2.1%, SQ +2%, GTS +2%, CBB +1.9%, ZAGG +1.8%, WK +1.8%, APHA +1.8%, CNP +1.8%, WNC +1.7%, TTI +1.6%, ABC +1.5%, CNQ +1.4%, DISH +1.4%, CXW +1.3%, EVOP +1.3%, DVAX +1.2%, TEVA +1.2%, CORE +1.1%, DISCA +1.1%

Other news:

  • UNIT +5.2% (declared quarterly dividend of $0.22/share)
  • CHRS +2.6% (acquired rights to commercialize Bioeq's biosimilar candidate to Lucentis in the US)
  • AVP +2.1% (Brazilian anti-trust authority approves co's acquisition by Natura)
  • AUPH +2.1% (completes FDA-requested clinical drug-drug interaction study in patients with lupus that investigated the potential effect of voclosporin on blood levels of mycophenolate acid)
  • CNHI +1.7% (launches new buy back program to repurchase up to $700 million in the Company's common shares)
  • RTIX +1.6% (Glen Capital Partners disclosed 6.9% active stake)
  • ARGX +1.5% (prices offering of 1,410,057 ADSs at a price of $121.00 per ADS and the sale of 2,589,943 ordinary shares at a price of €109.18 per ordinary share)
  • ARVN +1.2% (prices offering of 4,545,455 shares of its common stock at $22.00 per share)
  • HPQ +0.8% (confirmed conversations with Xerox [XRX] regarding potential combination)

Analyst comments:

  • REGN +1% (upgraded to Buy from Neutral at Citigroup)